Forty-four states accuse Teva Pharmaceutical of inflating drug prices

Forty-four U.S. states, led by Connecticut Attorney General William Tong, claim that 20 drug companies, including Teva USA, "systematically" divided up the market for generic drugs to avoid competing with one another, according to 500-page lawsuit filed late Friday in the U.S. District Court in Connecticut.
Mon, May 13 201912:41 PM EDT